−1000KRW
−11.59 BKRW
10.29 BKRW
6.15 M
About THE CURACLE
Sector
Headquarters
Seongnam-si
Employees (FY)
34
Website
Founded
2016
ISIN
KR7365270008
FIGI
BBG011F820L6
Curacle Co., Ltd. is engaged in the business of research and experimental development on medical sciences and pharmacy. It develops drugs for diabetes and stroke. The company was founded by Yeong-Geun, Kwon on May 12, 2016 and is headquartered in Seongnam-si, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 365270 is 17800 KRW — it has increased by 4.64% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange THE CURACLE stocks are traded under the ticker 365270.
365270 stock is 12.61% volatile and has beta coefficient of 1.46. Check out the list of the most volatile stocks — is THE CURACLE there?
Yes, you can track THE CURACLE financials in yearly and quarterly reports right on TradingView.
365270 stock has fallen by 1.71% compared to the previous week, the month change is a 16.80% rise, over the last year THE CURACLE has showed a 60.50% increase.
365270 net income for the last quarter is −5.67 B KRW, while the quarter before that showed −3.51 B KRW of net income which accounts for −61.55% change. Track more THE CURACLE financial stats to get the full picture.
Today THE CURACLE has the market capitalization of 235.68 B, it has increased by 39.63% over the last week.
No, 365270 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 365270 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade THE CURACLE stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 20, 2024, the company has 34.00 employees. See our rating of the largest employees — is THE CURACLE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So THE CURACLE technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating THE CURACLE stock shows the buy signal. See more of THE CURACLE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. THE CURACLE EBITDA is −12.02 B KRW, and current EBITDA margin is −94.67%. See more stats in THE CURACLE financial statements.